Clinical Trial Update: Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab [NA]

View source ↗

Summary

Completed clinical trial assessing the immune response to influenza vaccination in patients with non-Hodgkin lymphoma treated with rituximab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Non-Hodgkin Lymphoma (NHL) | NA | Status: COMPLETED